4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-070991
Director sold 818,044 shares at an average $0.96 ($785,027)
From the SEC's structured data for this filing
Trades in this filing
PAKIANATHAN DEEPIKA · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-05 | Sale : show line 1 in the form | −463,518 | $0.96 | $444,143 | 346,615 | I |
| 2024-06-05 | Sale : show line 2 in the form | −4,526 | $0.96 | $4,337 | 3,385 | I |
| 2024-06-06 | Sale : show line 3 in the form | −117,307 | $0.98 | $115,289 | 229,308 | I |
| 2024-06-06 | Sale : show line 4 in the form | −1,145 | $0.98 | $1,125 | 2,240 | I |
| 2024-06-07 | Sale : show line 5 in the form | −229,308 | $0.95 | $218,003 | 0 | I |
| 2024-06-07 | Sale : show line 6 in the form | −2,240 | $0.95 | $2,130 | 0 | I |
| Open-market sales · 818,044 sh · avg $0.96 · $785,027 | ||||||
Loading xslF345X05/ownership.xml…